288 related articles for article (PubMed ID: 31258791)
1. MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors.
Li X; Xu M; Ding L; Tang J
J Cancer; 2019; 10(12):2836-2848. PubMed ID: 31258791
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers.
Zhou M; Wu Y; Li H; Zha X
J Cancer; 2020; 11(22):6716-6726. PubMed ID: 33046994
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.
Zhang J; Cao Z; Yang G; You L; Zhang T; Zhao Y
Front Oncol; 2019; 9():893. PubMed ID: 31572683
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
5. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor.
Li Y; Li J; Sun X; Chen J; Sun X; Zheng J; Chen R
Oncol Lett; 2016 Jun; 11(6):4217-4223. PubMed ID: 27313769
[TBL] [Abstract][Full Text] [Related]
7. Promising therapeutic role of miR-27b in tumor.
Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J
Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320
[TBL] [Abstract][Full Text] [Related]
8. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
Ma Y; Yu S; Zhao W; Lu Z; Chen J
Cancer Lett; 2010 Dec; 298(2):150-8. PubMed ID: 20638779
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
Maqbool R; Lone SN; Ul Hussain M
Biochem J; 2016 Oct; 473(20):3597-3610. PubMed ID: 27531966
[TBL] [Abstract][Full Text] [Related]
10. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
[TBL] [Abstract][Full Text] [Related]
11. The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.
Li W; Yu ZX; Ma BF
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5490-5498. PubMed ID: 30229820
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility.
Yang Q; Jie Z; Ye S; Li Z; Han Z; Wu J; Yang C; Jiang Y
Oncogene; 2014 Jan; 33(2):193-202. PubMed ID: 23246964
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27a directly targets
Jiang Y; Duan Y; Zhou H
Oncol Lett; 2015 Jan; 9(1):471-477. PubMed ID: 25436011
[TBL] [Abstract][Full Text] [Related]
14. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).
Kim J; Fiesel FC; Belmonte KC; Hudec R; Wang WX; Kim C; Nelson PT; Springer W; Kim J
Mol Neurodegener; 2016 Jul; 11(1):55. PubMed ID: 27456084
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
[TBL] [Abstract][Full Text] [Related]
16. miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7.
Zhao W; Zhang X; Liu J; Sun B; Tang H; Zhang H
Oncol Rep; 2016 Dec; 36(6):3691-3699. PubMed ID: 27779715
[TBL] [Abstract][Full Text] [Related]
17. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
[TBL] [Abstract][Full Text] [Related]
18. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
Zhu L; Wang Z; Fan Q; Wang R; Sun Y
Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
[TBL] [Abstract][Full Text] [Related]
19. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression.
Zheng F; Wang M; Li Y; Huang C; Tao D; Xie F; Zhang H; Sun J; Zhang C; Gu C; Wang Z; Jiang G
Cancer Lett; 2019 Sep; 460():139-151. PubMed ID: 31255724
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
